Literature DB >> 14746878

Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease.

Catia Scassellati1, Roberta Zanardini, Rosanna Squitti, Luisella Bocchio-Chiavetto, Cristian Bonvicini, Giuliano Binetti, Orazio Zanetti, Emanuele Cassetta, Massimo Gennarelli.   

Abstract

Clinical and immunopathological evidence support a potential role of the pro- and anti-inflammatory cytokine network in neurodegeneration of Alzheimer's disease (AD). Moreover, association studies suggest a possible involvement of cytokine-related genes in the susceptibility to sporadic AD. Since conflicting results are associated with the pro-inflammatory pathway, we investigated a putative effect of the anti-inflammatory counterpart focusing on the interleukin-10 (IL-10) gene. The 5' flanking region contains numerous polymorphisms; in particular, three single nucleotide polymorphisms (-1082 G/A, -819 T/C, -592 C/A) are in linkage disequilibrium resulting in three haplotypes GCC, ACC and ATA. We analyzed the IL-10 haplotype distributions in 215 Italian sporadic AD patients and 153 controls in an association case-control study. Haplotype frequencies did not reveal differences between the two samples, however the genotype GCC/ACC was more represented in AD patients (OR 1.91, 95% CI: 1.18-3.07). This putative risk factor could be independent of the presence of the ApoE epsilon 4 allele. Our results provide new insights on a possible involvement of the IL-10 gene in susceptibility to sporadic AD even though further functional and genetic investigations are necessary to clarify its role in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14746878     DOI: 10.1016/j.neulet.2003.11.033

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Cytokine polymorphisms and Alzheimer disease: possible associations.

Authors:  G Ribizzi; S Fiordoro; S Barocci; E Ferrari; M Megna
Journal:  Neurol Sci       Date:  2010-03-06       Impact factor: 3.307

Review 2.  Let's make microglia great again in neurodegenerative disorders.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  J Neural Transm (Vienna)       Date:  2017-10-12       Impact factor: 3.575

3.  Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

Authors:  Qing Lan; Tongzhang Zheng; Nathaniel Rothman; Yawei Zhang; Sophia S Wang; Min Shen; Sonja I Berndt; Shelia H Zahm; Theodore R Holford; Brian Leaderer; Meredith Yeager; Robert Welch; Peter Boyle; Bing Zhang; Kaiyong Zou; Yong Zhu; Stephen Chanock
Journal:  Blood       Date:  2006-01-31       Impact factor: 22.113

4.  Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer.

Authors:  Juliana Garcia de Oliveira; Ana Flávia Teixeira Rossi; Daniela Manchini Nizato; Aline Cristina Targa Cadamuro; Yvana Cristina Jorge; Marina Curado Valsechi; Larissa Paola Rodrigues Venâncio; Paula Rahal; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo; Ana Elizabete Silva
Journal:  Tumour Biol       Date:  2015-06-19

5.  Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.

Authors:  Marie-Victoire Guillot-Sestier; Kevin R Doty; David Gate; Javier Rodriguez; Brian P Leung; Kavon Rezai-Zadeh; Terrence Town
Journal:  Neuron       Date:  2015-01-22       Impact factor: 17.173

6.  Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population.

Authors:  Fanjun Kong; Jie Liu; Yongheng Liu; Bao Song; Hualing Wang; Wenchao Liu
Journal:  J Exp Clin Cancer Res       Date:  2010-06-17

7.  Genetic association of IL-10 gene promoter polymorphism and HIV-1 infection in North Indians.

Authors:  Animesh Chatterjee; Anurag Rathore; P Sivarama; Naohiko Yamamoto; Tapan N Dhole
Journal:  J Clin Immunol       Date:  2008-08-06       Impact factor: 8.317

8.  Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production.

Authors:  Collins Ouma; Gregory C Davenport; Tom Were; Michael F Otieno; James B Hittner; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  Hum Genet       Date:  2008-10-30       Impact factor: 4.132

9.  Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans.

Authors:  S Taudorf; K S Krabbe; R M G Berg; K Møller; B K Pedersen; H Bruunsgaard
Journal:  Clin Exp Immunol       Date:  2008-02-25       Impact factor: 4.330

Review 10.  Innate Immunity Fights Alzheimer's Disease.

Authors:  Marie-Victoire Guillot-Sestier; Kevin R Doty; Terrence Town
Journal:  Trends Neurosci       Date:  2015-11       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.